Showing results (71-80 of 94) with videos related to

Sort By:
Pageof 10
Plos One|January 4, 2013
The clinically-tested S1P receptor agonists, FTY720 and BAF312, demonstrate subtype-specific bradycardia (S1P₁) and hypertension (S1P₃) in ratRyan M Fryer, Akalushi Muthukumarana, Paul C Harrison, et al.
Bioorganic & Medicinal Chemistry Letters|February 27, 2009
Novel N-substituted 2-phenyl-1-sulfonylamino-cyclopropane carboxylates as selective ADAMTS-5 (Aggrecanase-2) inhibitorsMakoto Shiozaki, Katsuya Maeda, Tomoya Miura, et al.
British Journal of Pharmacology|December 18, 2007
Effect of bradykinin metabolism inhibitors on evoked hypotension in rats: rank efficacy of enzymes associated with bradykinin-mediated angioedemaR M Fryer, J Segreti, P N Banfor, et al.
Journal of Cardiovascular Pharmacology|July 27, 2005
Pharmacological characterization of the novel dihydropyridine potassium channel opener, (9R)-9-(3-iodo-4-methylphenyl)-5,9-dihydro-3H-furo[3,4-b]pyrano[4,3-e]pyridine-1,8(4H,7H)-dione (A-325100), and the regulation of cardiovascular function in conscious and anesthetized beagle dogsRyan M Fryer, Pamela A Rakestraw, Lee C Preusser, et al.
American Journal of Physiology. Heart and Circulatory Physiology|May 20, 2008
Reduced heart size and increased myocardial fuel substrate oxidation in ACC2 mutant miceM Faadiel Essop, Heidi S Camp, Cheol Soo Choi, et al.
Circulation Research|March 8, 2003
12-lipoxygenase in opioid-induced delayed cardioprotection: gene array, mass spectrometric, and pharmacological analysesHemal H Patel, Ryan M Fryer, Eric R Gross, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 4, 2009
Effect of the multitargeted receptor tyrosine kinase inhibitor, ABT-869 [N-(4-(3-amino-1H-indazol-4-yl)phenyl)-N'-(2-fluoro-5-methylphenyl)urea], on blood pressure in conscious rats and mice: reversal with antihypertensive agents and effect on tumor growth inhibitionPamela H Franklin, Patricia N Banfor, Paul Tapang, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 6, 2016
A Soluble Guanylate Cyclase Activator Inhibits the Progression of Diabetic Nephropathy in the ZSF1 RatCarine M Boustany-Kari, Paul C Harrison, Hongxing Chen, et al.
Bioorganic & Medicinal Chemistry Letters|September 22, 2009
Synthesis and SAR of 2-phenyl-1-sulfonylaminocyclopropane carboxylates as ADAMTS-5 (Aggrecanase-2) inhibitorsMakoto Shiozaki, Hiroto Imai, Katsuya Maeda, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 2, 2022
Effect of Novel Biotherapeutic Elevating Angiopoietin 1 on Progression of Diabetic Nephropathy in Diabetic/Obese MicePeng Sun, Christina S Bartlett, Chao Zheng, et al.
Pageof 10